Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Dermatology Reports

02-03-2024 | Vulgar Psoriasis | REVIEW

Oral Psoriasis—An Overlooked Entity: Current Paradigms and Future Perspectives

Authors: Simranjit Singh, Pratibha Ramani, N. D. Jayakumar, Tanvi Handa, Rose Kanwaljeet Kaur, Ravi Kant Sharma, Anil Kumar Sharma

Published in: Current Dermatology Reports

Login to get access

Abstract

Purpose of Review

Psoriasis is a chronic, genetically determined, scaly, and inflammatory disease of the skin. Pathogenesis is multi-factorial, involving dysregulated inflammation and genetic associations. Cutaneous lesions are characterized as thick, erythematous, all-around defined plaques covered with a silvery white scale. Commonly affected areas include the elbows, knees, sacral area, and scalp. One of the factors that may result in the appearance of psoriatic lesions may be the oral cavity lesions. Aim of the present article was to review the effects of psoriasis on oral cavity, histopathological investigations, and etiopathogenesis and diagnosis of oral psoriasis.

Recent Findings

Recently, many therapies for oral psoriasis are observed and some are in development, or under investigation. Regular non-biologic therapeutic options for psoriasis like cyclosporine, methotrexate, and acitretin are usually not recommended for long-term use due to their adverse safety profiles. More recently, biomarkers present in the oral fluids have been tested as diagnostic tool for psoriasis using gingival crevicular fluid.

Summary

In this review article, we have provided an insight vision to the etiopathogenesis, clinical features, diagnostic criteria, and treatment of oral psoriasis. Apart from this, a strong emphasis is given to the oral manifestations presented by psoriatic patients, its association with geographic tongue, and salivary changes seen in psoriasis.
Literature
1.
2.
Krueger GG, Duvic M. Epidemiology of psoriasis: clinical issues. J Invest Dermatol. 1994;102(6):14S-18S.PubMedCrossRef
3.
• Ali Hassan S, Bhateja S. Psoriasis of oral cavity - a review. IP Indian J Clin Exp Dermatol. 2020;6(2):113–6. This article is of importance as it emphasizes the various parts of the oral cavity affected by psoriasis.
4.
Zhu J-F, Kaminski M, Pulitzer D, Hu J, Thomas H. Psoriasis: pathophysiology and oral manifestations. Oral Dis. 2008;2(2):135–44.CrossRef
5.
•• Bruce AJ, Rogers RS. Oral psoriasis. Dermatol Clin. 2003;21(1):99–104. This article emphasizes the importance of detailed history in diagnosis of psoriasis because a family history of psoriasis or a history of psoriasis now in remission may guide physicians when they note oral lesions.
6.
Cataldo E, McCarthy P, Yaffee H. Psoriasis with oral manifestations. Cutis. 1977;20(6):705–8.PubMed
7.
• Younai FS, Phelan JA. Oral mucositis with features of psoriasis. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontology. 1997;84(1):61–7. The review of the literature compares the distribution and clinical appearance of previously reported cases of oral psoriasis.
8.
Yesudian PD, Chalmers RJG, Warren RB, Griffiths CEM. In search of oral psoriasis. Arch Dermatol Res. 2012;304(1):1–5.PubMedCrossRef
9.
Naldi L, Mercury SR. Epidemiology of comorbidities in psoriasis. Dermatol Ther. 2010;23(2):114–8.PubMedCrossRef
10.
11.
Shafer WG, Hine MK, Levy BM. A textbook of oral pathology. 4th ed. Philadelphia: Saunders; 1983. p. 917.
12.
Neville BW, Damm DD, Allen CM, Chi AC. Oral and maxillofacial pathology. 4th ed. St. Louis, Missouri: Elsevier; 2016. p. 912.
13.
14.
•• Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA. 2020;323(19):1945. Plaque psoriasis is the most common variant of psoriasis. The most rapid advancements addressing plaque psoriasis have been in its pathogenesis, genetics, comorbidities, and biologic treatments. Plaque psoriasis is associated with a number of comorbidities including psoriatic arthritis, cardiometabolic diseases, and depression.
15.
Raharja A, Mahil SK, Barker JN. Psoriasis: a brief overview. Clin Med. 2021;21(3):170–3.CrossRef
16.
Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker JNWN. Psoriasis. The Lancet. 2021;397(10281):1301–15.CrossRef
17.
Hoegler KM, John AM, Handler MZ, Schwartz RA. Generalized pustular psoriasis: a review and update on treatment. J Eur Acad Dermatol Venereol. 2018;32(10):1645–51.PubMedCrossRef
18.
Raychaudhuri SK, Maverakis E, Raychaudhuri SP. Diagnosis and classification of psoriasis. Autoimmun Rev. 2014;13(4–5):490–5.PubMedCrossRef
19.
• Fatahzadeh M, Schwartz RA. Oral psoriasis: an overlooked enigma. Dermatology. 2016;232(3):319–25. Highlights on oral psoriasis, its variable clinical appearance, differential diagnosis, and management strategies.
20.
21.
22.
Lier GC, Mrowietz U, Wolfart M, Warnke PH, Wiltfang J, Springer ING. Psoriasis of the tongue. J Cranio-Maxillofac Surg. 2009;37(1):51–3.CrossRef
23.
Mattsson U, Warfvinge G, Jontell M. Oral psoriasis—a diagnostic dilemma: a report of two cases and a review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;120(4):e183–9.PubMedCrossRef
24.
• van der Waal I, Pindborg JJ. Diseases of the tongue. Chicago: Quintessence Pub. Co; 1986. p. 199. Highlights on both common and rare diseases occurring on the surface of the tongue.
25.
Richardson LJ, Kratochvil FJ, Zieper MB. Unusual palatal presentation of oral psoriasis. J Can Dent Assoc. 2000;66(2):80–2.PubMed
26.
Tosti A, Misciali C, Cameli N, Vincenzi C. Guess what! Psoriasis of the lips. Eur J Dermatol EJD. 2001;11(6):589–90.PubMed
27.
28.
Yamamoto T, Nishioka K. Oral psoriasis in a patient with hepatitis C virus infection. Eur J Dermatol EJD. 2002;12(1):75–6.PubMed
29.
Gül Ü, Kılıç A, Gönül M, Soylu S, Bilgili S, Han Ö. Psoriasis of the lips: an unusual localization. Int J Dermatol. 2006;45(11):1381–2.PubMedCrossRef
30.
• Buchner A, Begleiter A. Oral lesions in psoriatic patients. Oral Surg Oral Med Oral Pathol. 1976;41(3):327–32. Highlights the possibility that benign migratory glossitis is an oral manifestation of psoriasis.
31.
32.
Pogrel MA, Cram D. Intraoral findings in patients with psoriasis with a special reference to ectopic geographic tongue (erythema circinata). Oral Surg Oral Med Oral Pathol. 1988;66(2):184–9.PubMedCrossRef
33.
O’Keefe E, Braverman IM, Cohen I. Annulus migrans: Identical lesions in pustular psoriasis, Reiter’s syndrome, and geographic tongue. Arch Dermatol. 1973;107(2):240–4.PubMedCrossRef
34.
Espelid M, Bang G, Johannessen AC, Leira JI, Christensen O. Geographic stomatitis: report of 6 cases. J Oral Pathol Med. 1991;20(9):425–8.PubMedCrossRef
35.
Ulmansky M, Michelle R, Azaz B. Oral psoriasis: report of six new cases. J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol. 1995;24(1):42–5.
36.
Yamada J, Amar S, Petrungaro P. Psoriasis-associated periodontitis: a case report. J Periodontol. 1992;63(10):854–7.PubMedCrossRef
37.
38.
Sklavounou A, Laskaris G. Oral psoriasis: report of a case and review of the literature. Dermatology. 1990;180(3):157–9.CrossRef
39.
Picciani BLS, Teixeira-Souza T, Curty ÁA, Izahias LMS, Pessoa TM, Carneiro S, et al. Unraveling oral psoriasis and its relationship with geographic tongue: a literature review. World J Dermatol. 2016;5(2):84.CrossRef
40.
Picciani BLS, Silva-Junior GO, Michalski-Santos B, Avelleira JCR, Azulay DR, Pires FR, et al. Prevalence of oral manifestations in 203 patients with psoriasis. J Eur Acad Dermatol Venereol JEADV. 2011;25(12):1481–3.PubMedCrossRef
41.
Hernández-Pérez F, Jaimes-Aveldañez A, Urquizo-Ruvalcaba MDL, Díaz-Barcelot M, Irigoyen-Camacho ME, Vega-Memije ME, et al. Prevalence of oral lesions in patients with psoriasis. Med Oral Patol Oral Cirugia Bucal. 2008;13(11):E703-8.
42.
Jainkittivong A, Langlais RP. Geographic tongue: clinical characteristics of 188 cases. J Contemp Dent Pract. 2005;6(1):E123-35.CrossRef
43.
44.
Honarmand M, FarhadMollashahi L, Shirzaiy M, Sehhatpour M. Geographic tongue and associated risk factors among Iranian dental patients. Iran J Public Health. 2013;42(2):215–9.PubMedPubMedCentral
45.
Gonzaga HFS, Chaves MD, Gonzaga LHS, Picciani BLS, Jorge MA, Dias EP, et al. Environmental factors in benign migratory glossitis and psoriasis: retrospective study of the association of emotional stress and alcohol and tobacco consumption with benign migratory glossitis and cutaneous psoriasis. J Eur Acad Dermatol Venereol JEADV. 2015;29(3):533–6.PubMedCrossRef
46.
Picciani BLS, Souza TT, Santos VDCB, Domingos TA, Carneiro S, Avelleira JC, et al. Geographic tongue and fissured tongue in 348 patients with psoriasis: correlation with disease severity. Sci World J. 2015;2015:564326.CrossRef
47.
Bhawan J, Bansal C, Whren K, Schwertschlag U, IL-11 Psoriasis Study Group. K16 expression in uninvolved psoriatic skin: a possible marker of pre-clinical psoriasis. J Cutan Pathol. 2004;31(7):471–6.PubMedCrossRef
48.
Santos VCB. Evaluation of clinical aspects of geographic tongue, and histopathological and immunohistochemistry of epithelial proliferation index of the cytokeratins CK6, CK16, CK17 and vascular changes in geographic tongue and psoriasis. Braz Fed Flum Univ Dep Pathol. 2015;(100).
49.
Ganzetti G, Campanati A, Santarelli A, Sartini D, Molinelli E, Brisigotti V, et al. Salivary interleukin-1β: oral inflammatory biomarker in patients with psoriasis. J Int Med Res. 2016;44(1_suppl):10–4.PubMedPubMedCentralCrossRef
50.
•• Martina E, Campanati A, Diotallevi F, Offidani A. Saliva and oral diseases. J Clin Med. 2020;9(2):466. The review aspires to provide an overall perspective of salivary biomarkers concerning oral diseases such as lichen planus, oral cancer, blistering diseases, and psoriasis. Saliva has proved to be a promising substrate for the early detection of oral diseases and the evaluation of therapeutic response.
51.
Marx RE, Stern D. Oral and maxillofacial pathology: a rationale for diagnosis and treatment. Hanover Park, IL: Quintessence Pub. Co.; 2012.
52.
De Rosa G, Mignogna C. The histopathology of psoriasis. Reumatismo. 2007;59(Suppl 1):46–8.PubMed
53.
Wooten JW, Tarsitano JJ, LaVere AM. Oral psoriasiform lesions: a possible prosthodontic complication. J Prosthet Dent. 1970;24(2):145–7.
54.
Weathers DR, Baker G, Archard HO, Jefferson BE. Psoriasiform lesions of the oral mucosa (with emphasis on ‘ectopic geographic tongue’). Oral Pathol. 1974;37:872–88.CrossRef
55.
56.
González-Moles MA, Scully C. Vesiculo-erosive oral mucosal disease—management with topical corticosteroids: fundamental principles and specific agents available. J Dent Res. 2005;84:294–301.PubMedCrossRef
57.
Dreyer LN, Brown GC. Oral manifestations of psoriasis: Clinical presentation and management. N Y State Dent J. 2012;78(3):14–8.PubMed
Metadata
Title
Oral Psoriasis—An Overlooked Entity: Current Paradigms and Future Perspectives
Authors
Simranjit Singh
Pratibha Ramani
N. D. Jayakumar
Tanvi Handa
Rose Kanwaljeet Kaur
Ravi Kant Sharma
Anil Kumar Sharma
Publication date
02-03-2024
Publisher
Springer US
Published in
Current Dermatology Reports
Electronic ISSN: 2162-4933
DOI
https://doi.org/10.1007/s13671-024-00424-0